Despite the Trump administration's tariff threats and pressure to move more manufacturing to the U.S., the push to raise ...

The 2025 Clinical Trial Supply West Coast conference will gather experts to discuss US trial operations in a shifting tariff ...

President Donald Trump plans to start with a “small tariff” on pharmaceutical imports before ramping duties up to 250% within ...

The Indian pharmaceutical industry has been excluded from the United States' latest round of tariff hikes, with Washington ...

The Canadian pharmaceutical industry is still waiting to learn about tariffs as high as 200 per cent on exports to the U.S.

The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 ...

Driven by lessons from the pandemic and a reliance on imports -- more than $2.16 billion in packaged medicines in 2023, most ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

Mark Cuban, the billionaire and Western Pennsylvania native now knee-deep in the pharmaceutical industry, offered strong ...

The tariffs are Trump’s way of getting drug companies to move more of their operations to the U.S. at a time when domestic ...

Indian drugmakers are responding with geographic diversification, supply-chain resilience and acquisition of US assets to ...

The Trump administration says it's aiming to lower drug costs for Americans. It's given drug companies 60 days to lower ...